Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More
you are here: HomeNewsIndia

Coronavirus pandemic | Confirmed COVID-19 cases in India cross 1-lakh mark; death toll at 3,163

India is the eleventh country to register one lakh or more COVID-19 cases.

May 19, 2020 / 08:58 AM IST
File image

File image

Confirmed cases of COVID-19 crossed the one lakh-mark in India on May 19, according to the Union Ministry of Health and Family Welfare.

According to the data last updated on the ministry’s website at 8.00 am on May 19, the total known cases of COVID-19, the disease caused by the novel coronavirus, reached 1,01,139. The death toll in the country due to the pandemic reached 3,163.

While 39,174 patients had recovered, 58,802 cases were still categorised as ‘active’. India had reported its first case of COVID-19 on January 30.

India is the eleventh country to register one lakh or more COVID-19 cases, according to Johns Hopkins University CSSE.

Maharashtra, Gujarat, Tamil Nadu and Delhi have reported the highest number of cases so far.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

Globally, there have been over 47.9 lakh confirmed cases of COVID-19. Of these, at least 3.18 lakh people have died so far. The United States, Russia, the United Kingdom, Brazil and Spain are the most-affected countries.

India has been under a nationwide lockdown since March 24. This lockdown has been extended till May 31.

(Please check back for more details)

Click here for Moneycontrol’s full coverage of the novel coronavirus pandemic
Moneycontrol News
first published: May 19, 2020 08:58 am

stay updated

Get Daily News on your Browser